Evidence map›Paper›PMID 41561860›Full record

ArticleFrontiers in public health2025

MDL-CA: a multimodal deep learning approach with a cross attention mechanism for accurate brain cancer diagnosis.

Sumaira Sarwar, Saqib Majeed, Asif Nawaz, Ruqia Bibi, Seung Won Lee

Abstract read
In one paragraph

Article in Frontiers in public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sumaira SarwarUniversity Institute of Information Technology, PMAS-Arid Agriculture University Rawalpindi, Rawalpindi, Pakistan.
Saqib MajeedUniversity Institute of Information Technology, PMAS-Arid Agriculture University Rawalpindi, Rawalpindi, Pakistan.
Asif NawazUniversity Institute of Information Technology, PMAS-Arid Agriculture University Rawalpindi, Rawalpindi, Pakistan.
Ruqia BibiUniversity Institute of Information Technology, PMAS-Arid Agriculture University Rawalpindi, Rawalpindi, Pakistan.
Seung Won LeeDepartment of Precision Medicine, Sungkyunkwan University School of Medicine, Suwon, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Brain cancer diagnosis poses a significant clinical challenge due to the complex interplay between molecular mechanisms and anatomical abnormalities. Traditional diagnostic techniques, including invasive biopsies, isolated genomic assays, and standalone Magnetic Resonance Imaging (MRI), often exhibit limitations such as procedural risks, inadequate sensitivity, and incomplete assessment of tumor heterogeneity. These shortcomings contribute to delayed diagnosis, inaccurate tumor grading, and suboptimal treatment planning. Furthermore, single-modality data, whether MRI or genomic profiles, frequently yield limited diagnostic accuracy and biological interpretability. Methods: To address these limitations, this study proposes MDL-CA, a Multimodal Deep Learning framework with a Cross-Attention mechanism, designed to integrate genomic and MRI modalities for enhanced brain cancer diagnosis. The framework fuses genomic graph embeddings, extracted using a Graph Attention Network (GAT), with MRI feature maps derived from a 3D DenseNet. The cross-modal attention fusion mechanism enables the model to capture intricate biological and spatial interactions, producing a biologically informed feature representation. Additionally, the Entmax sigmoid function is employed in the classification stage to promote sparsity and improve interpretability. Data were sourced from The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA) following comprehensive preprocessing. Results: Extensive experiments conducted across four benchmark datasets demonstrated that MDL-CA achieved superior diagnostic performance, with accuracies of 96.22%, 97.14%, 98.46%, and 98.21%, and F1-scores ranging from 95.95% to 98.40%. These results confirm the framework's robustness, scalability, and consistent generalization across diverse datasets. Discussion: The integration of genomic and MRI data through the proposed cross-attention mechanism enables deeper biological understanding and improved diagnostic precision compared to single-modality and conventional fusion approaches. By effectively modeling interactions between molecular and anatomical features, MDL-CA advances the development of biologically informed, multimodal diagnostic systems for brain cancer. The results highlight the framework's potential to support early diagnosis and personalized treatment planning in clinical practice.

Indexed as

Brain NeoplasmsDeep LearningMagnetic Resonance ImagingGenomicsHumans3D DenseNetbrain cancerdeep learningEntmaxGATmultimodality

Identifiers

PMID41561860
PMCPMC12812965

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.